{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T16:39:53Z","timestamp":1789058393671,"version":"build-2803163510"},"reference-count":27,"publisher":"Oxford University Press (OUP)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,11,13]]},"DOI":"10.1093\/cid\/cix639","type":"journal-article","created":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T11:18:43Z","timestamp":1501586323000},"page":"1843-1847","source":"Crossref","is-referenced-by-count":36,"title":["Effectiveness of Measles Vaccination and Immune Globulin Post-Exposure Prophylaxis in an Outbreak Setting\u2014New York City, 2013"],"prefix":"10.1093","volume":"65","author":[{"given":"Robert J","family":"Arciuolo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel R","family":"Jablonski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane R","family":"Zucker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer B","family":"Rosen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,9,23]]},"reference":[{"key":"key\n\t\t\t\t20171113035735_CIT0001","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1038\/2011054a0","article-title":"Survival of measles virus in air","volume":"201","year":"1964","journal-title":"Nature"},{"key":"key\n\t\t\t\t20171113035735_CIT0002","first-page":"1","article-title":"Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: summary recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"62","author":"Centers for Disease Control and Prevention","year":"2013","journal-title":"MMWR Recomm Rep"},{"key":"key\n\t\t\t\t20171113035735_CIT0003","first-page":"209","article-title":"Measles","volume-title":"Epidemiology and prevention of vaccine-preventable diseases","author":"Centers for Disease Control and Prevention","year":"2015","edition":"13th ed"},{"key":"key\n\t\t\t\t20171113035735_CIT0004","volume-title":"Measles. Manual for the surveillance of vaccine-preventable diseases","author":"Centers for Disease Control and Prevention","year":"2013","edition":"5th ed"},{"key":"key\n\t\t\t\t20171113035735_CIT0005","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1086\/377712","article-title":"The clinical significance of measles: a review","volume":"189","year":"2004","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20171113035735_CIT0006","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.1086\/378565","article-title":"Acute measles mortality in the United States, 1987\u20132002","volume":"189","year":"2004","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20171113035735_CIT0007","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1086\/377693","article-title":"Measles elimination in the United States","volume":"189","year":"2004","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20171113035735_CIT0008","first-page":"373","article-title":"Measles\u2014United States, January 4\u2013April 2, 2015","volume":"64","author":"Centers for Disease Control and Prevention","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key\n\t\t\t\t20171113035735_CIT0009","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1172\/JCI101519","article-title":"Chemical, clinical, and immunological studies on the products of human plasma fractionation. xii. The use of concentrated normal human serum gamma globulin (human immune serum globulin) in the prevention and attenuation of measles","volume":"23","year":"1944","journal-title":"J Clin Invest"},{"key":"key\n\t\t\t\t20171113035735_CIT0010","first-page":"202","article-title":"Use of concentrated human serum gamma-globulin in the prevention and attenuation of measles","volume":"21","year":"1945","journal-title":"Bull N Y Acad Med"},{"key":"key\n\t\t\t\t20171113035735_CIT0011","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1136\/bmj.1.5334.860","article-title":"Protection after exposure to measles by attenuated vaccine without gamma-globulin","volume":"1","year":"1963","journal-title":"Br Med J"},{"key":"key\n\t\t\t\t20171113035735_CIT0012","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1056\/NEJM196307112690204","article-title":"Use of live-measles-virus vaccine to abort an expected outbreak of measles within a closed population","volume":"269","year":"1963","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20171113035735_CIT0013","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1007\/BF01253826","article-title":"Simultaneous measles exposure and immunization","volume":"16","year":"1965","journal-title":"Arch Gesamte Virusforsch"},{"key":"key\n\t\t\t\t20171113035735_CIT0014","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0022-3476(78)80597-6","article-title":"Measles vaccination after exposure to natural measles","volume":"93","year":"1978","journal-title":"J Pediatr"},{"key":"key\n\t\t\t\t20171113035735_CIT0015","first-page":"883","article-title":"Clinical efficacy of measles vaccine during the 1990 measles epidemic","volume":"10","year":"1991","journal-title":"Pediatr Infect Dis J"},{"key":"key\n\t\t\t\t20171113035735_CIT0016","first-page":"969","article-title":"Postexposure prophylaxis, isolation, and quarantine to control an import-associated measles outbreak\u2014Iowa, 2004","volume":"53","author":"Centers for Disease Control and Prevention","year":"2004","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key\n\t\t\t\t20171113035735_CIT0017","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0140-6736(04)15553-0","article-title":"MMR immunisation after contact with measles virus","volume":"363","year":"2004","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20171113035735_CIT0018","first-page":"304","article-title":"Severity of measles among patients with incidental postexposure vaccination","volume":"61","year":"2008","journal-title":"Jpn J Infect Dis"},{"key":"key\n\t\t\t\t20171113035735_CIT0019","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1071\/NB08014","article-title":"The effectiveness of prophylaxis for measles contacts in NSW","volume":"20","year":"2009","journal-title":"N S W Public Health Bull"},{"key":"key\n\t\t\t\t20171113035735_CIT0020","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1097\/INF.0b013e3181f7001c","article-title":"Effectiveness of measles vaccination for control of exposed children","volume":"30","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"key\n\t\t\t\t20171113035735_CIT0021","first-page":"CD010056","article-title":"Post-exposure passive immunisation for preventing measles","volume":"4","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"key\n\t\t\t\t20171113035735_CIT0022","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1016\/j.vaccine.2017.03.069","article-title":"Estimated protective effectiveness of intramuscular immune serum globulin post-exposure prophylaxis during a measles outbreak in British Columbia, Canada, 2014","volume":"35","year":"2017","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20171113035735_CIT0023","first-page":"752","article-title":"Notes from the field: measles outbreak among members of a religious community\u2014Brooklyn, New York, March\u2013June 2013","volume":"62","year":"2013","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key\n\t\t\t\t20171113035735_CIT0024","volume-title":"New York City Health Code \u00a711.07, Reportable Diseases and Conditions. Available at"},{"key":"key\n\t\t\t\t20171113035735_CIT0025","volume-title":"Immunization information system annual report 2013","author":"New York City Department of Health and Mental Hygiene","year":"2013"},{"key":"key\n\t\t\t\t20171113035735_CIT0026","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1172\/JCI101518","article-title":"Chemical, clinical, and immunological studies on the products of human plasma fractionation. xi. The use of concentrated normal human serum gamma globulin (human immune serum globulin) in the prophylaxis and treatment of measles","volume":"23","year":"1944","journal-title":"J Clin Invest"},{"key":"key\n\t\t\t\t20171113035735_CIT0027","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1067\/mpd.2001.113710","article-title":"Current efficacy of postexposure prophylaxis against measles with immunoglobulin","volume":"138","year":"2001","journal-title":"J Pediatr"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/65\/11\/1843\/21676861\/cix639.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,11,13]],"date-time":"2017-11-13T08:57:52Z","timestamp":1510563472000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/cid\/article\/65\/11\/1843\/4210618"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,23]]},"references-count":27,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2017,9,23]]},"published-print":{"date-parts":[[2017,11,13]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/cix639","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,12,1]]},"published":{"date-parts":[[2017,9,23]]}}}